This study investigates the hypothesis that hAM hydrogel, rich in diverse growth factors including pro-angiogenic factors like platelet-derived growth factor, vascular endothelial growth factor, transforming growth factor beta, and possessing anti-inflammatory properties, can mitigate some of the complications associated with ischemia (17). This evidence concerns the gene VEGFA and ischemia.